SG11201806125UA - Novel bisphosphonic acid compound - Google Patents

Novel bisphosphonic acid compound

Info

Publication number
SG11201806125UA
SG11201806125UA SG11201806125UA SG11201806125UA SG11201806125UA SG 11201806125U A SG11201806125U A SG 11201806125UA SG 11201806125U A SG11201806125U A SG 11201806125UA SG 11201806125U A SG11201806125U A SG 11201806125UA SG 11201806125U A SG11201806125U A SG 11201806125UA
Authority
SG
Singapore
Prior art keywords
acid compound
bisphosphonic acid
novel bisphosphonic
novel
compound
Prior art date
Application number
SG11201806125UA
Other languages
English (en)
Inventor
Seiichi Kobashi
Yoshinobu Aoyagi
Hiroshige Kato
Ryuko Tokuyama
Naoki Ashizawa
Koichi Ishida
Koji Matsumoto
Original Assignee
Fujiyakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujiyakuhin Co Ltd filed Critical Fujiyakuhin Co Ltd
Publication of SG11201806125UA publication Critical patent/SG11201806125UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/386Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3843Polyphosphonic acids containing no further substituents than -PO3H2 groups
    • C07F9/3852Cycloaliphatic derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3856Polyphosphonic acids containing halogen or nitro(so) substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3865Polyphosphonic acids containing sulfur substituents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201806125UA 2016-01-29 2017-01-27 Novel bisphosphonic acid compound SG11201806125UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016027405 2016-01-29
PCT/JP2017/002855 WO2017131127A1 (ja) 2016-01-29 2017-01-27 新規ビスホスホン酸化合物

Publications (1)

Publication Number Publication Date
SG11201806125UA true SG11201806125UA (en) 2018-08-30

Family

ID=59398507

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806125UA SG11201806125UA (en) 2016-01-29 2017-01-27 Novel bisphosphonic acid compound

Country Status (19)

Country Link
US (1) US10689408B2 (zh)
EP (1) EP3409679A4 (zh)
JP (1) JP6259957B2 (zh)
KR (1) KR20180111791A (zh)
CN (1) CN108473518B (zh)
AR (1) AR107472A1 (zh)
AU (1) AU2017211464B9 (zh)
BR (1) BR112018015552A2 (zh)
CA (1) CA3012957A1 (zh)
CO (1) CO2018007788A2 (zh)
HK (1) HK1257616A1 (zh)
MX (1) MX2018009231A (zh)
MY (1) MY195906A (zh)
PH (1) PH12018501586A1 (zh)
RU (1) RU2731615C2 (zh)
SG (1) SG11201806125UA (zh)
TW (1) TWI730039B (zh)
WO (1) WO2017131127A1 (zh)
ZA (1) ZA201804945B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102651652B1 (ko) 2018-10-11 2024-03-26 사니핏 테라퓨틱스 에스.에이. 이소성 석회화의 치료를 위한 이노시톨 포스페이트
EP4015494A1 (en) 2020-12-15 2022-06-22 Sanifit Therapeutics S.A. Processes for the preparation of soluble salts of inositol phosphates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540150A1 (de) 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DD298267A5 (de) * 1989-01-27 1992-02-13 Zentralinstitut Fuer Molekularbiologie,De Verfahren zur immobilisierung von lipase, beta-galactosidase oder invertase
FI89366C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
FI89364C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya, farmakologiskt anvaendbara metylenbisfosfonsyraderivat
JPH07507315A (ja) 1992-05-29 1995-08-10 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド カルシウムおよびホスフェート代謝異常治療用含硫ホスホネート化合物
ES2111163T3 (es) * 1992-06-30 1998-03-01 Procter & Gamble Pharma Uso de fosfonatos para el tratamiento de la osteoporosis.
AU2756701A (en) 2000-01-04 2001-07-16 Regents Of The University Of California, The Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification
TW200410700A (en) 2002-10-15 2004-07-01 Novartis Ag New uses of and devices comprising bisphosphonates
CN1705486A (zh) * 2002-10-15 2005-12-07 诺瓦提斯公司 用于治疗动脉粥样硬化的双膦酸类化合物和包含它们的装置
US8012949B2 (en) 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
JP2009530414A (ja) * 2006-03-17 2009-08-27 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ ビスホスホネート化合物及び方法
FR2926080B1 (fr) * 2008-01-03 2010-04-02 Univ Nantes Procede de synthese de derives d'acide hydroxy-bisphosphonique

Also Published As

Publication number Publication date
HK1257616A1 (zh) 2019-10-25
AR107472A1 (es) 2018-05-02
AU2017211464B9 (en) 2021-07-22
US10689408B2 (en) 2020-06-23
RU2731615C2 (ru) 2020-09-07
TW201728332A (zh) 2017-08-16
AU2017211464A1 (en) 2018-08-09
CN108473518A (zh) 2018-08-31
JP6259957B2 (ja) 2018-01-10
MX2018009231A (es) 2018-11-09
WO2017131127A1 (ja) 2017-08-03
CO2018007788A2 (es) 2018-08-10
MY195906A (en) 2023-02-27
EP3409679A4 (en) 2019-11-06
CA3012957A1 (en) 2017-08-03
BR112018015552A2 (pt) 2018-12-26
US20190002482A1 (en) 2019-01-03
AU2017211464B2 (en) 2021-07-01
ZA201804945B (en) 2019-09-25
PH12018501586A1 (en) 2019-04-08
EP3409679A1 (en) 2018-12-05
KR20180111791A (ko) 2018-10-11
CN108473518B (zh) 2021-07-06
JPWO2017131127A1 (ja) 2018-02-01
RU2018130994A (ru) 2020-03-03
TWI730039B (zh) 2021-06-11
RU2018130994A3 (zh) 2020-03-13

Similar Documents

Publication Publication Date Title
HK1256059A1 (zh) 新化合物
HK1243410A1 (zh) 新型化合物
GB201521109D0 (en) Novel compounds
GB201522768D0 (en) Novel compounds
GB201506871D0 (en) Novel compounds
GB201501462D0 (en) Novel compounds
GB201522179D0 (en) Novel compounds
HK1255832A1 (zh) 吡喃並二吡啶化合物
GB201504565D0 (en) Novel compounds
GB201521524D0 (en) Compound
GB201502675D0 (en) Novel compounds
HK1257616A1 (zh) 新雙膦酸化合物
GB201617103D0 (en) Compound
GB201612652D0 (en) Novel compound
GB201610497D0 (en) Compound
GB201518950D0 (en) Compound
HK1251574A1 (zh) 四氫噁庚英吡啶化合物
GB201619531D0 (en) Compound
GB201619526D0 (en) Compound
GB201613035D0 (en) Compound
GB201608591D0 (en) Compound
GB201520393D0 (en) Compound
GB201520391D0 (en) Compound
GB201521749D0 (en) Novel compounds
GB201521713D0 (en) Novel compounds